Ing Groep Nv Incyte Corp Transaction History

Ing Groep Nv

$16.5 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$56.55 - $66.59 $937,372 - $1.1 Million	-16,576 Reduced 15.54%	90,089 $5.13 Million
Q4 2023 Feb 08, 2024	BUY	$52.16 - $64.19 $4.35 Million - $5.35 Million	83,315 Added 356.81%	106,665 $6.7 Million
Q3 2023 Oct 27, 2023	SELL	$57.77 - $65.93 $179,087 - $204,383	-3,100 Reduced 11.72%	23,350 $1.35 Million
Q2 2023 Aug 07, 2023	SELL	$60.95 - $75.51 $304,567 - $377,323	-4,997 Reduced 15.89%	26,450 $1.65 Million
Q1 2023 May 09, 2023	BUY	$70.23 - $86.01 $2.21 Million - $2.7 Million	31,447 New	31,447 $2.27 Million
Q3 2022 Nov 14, 2022	SELL	$66.18 - $82.86 $429,839 - $538,175	-6,495 Reduced 18.33%	28,935 $1.93 Million
Q2 2022 Aug 08, 2022	BUY	$66.18 - $83.18 $1.66 Million - $2.09 Million	25,097 Added 242.88%	35,430 $2.69 Million
Q1 2022 May 13, 2022	SELL	$66.02 - $79.71 $935,701 - $1.13 Million	-14,173 Reduced 57.83%	10,333 $821,000
Q4 2021 Feb 11, 2022	BUY	$63.34 - $74.11 $307,832 - $360,174	4,860 Added 24.74%	24,506 $1.8 Million
Q3 2021 Nov 02, 2021	BUY	$68.67 - $84.02 $28,498 - $34,868	415 Added 2.16%	19,646 $1.35 Million
Q2 2021 Aug 13, 2021	BUY	$79.87 - $87.53 $547,828 - $600,368	6,859 Added 55.44%	19,231 $1.62 Million
Q1 2021 May 12, 2021	BUY	$76.02 - $100.5 $1,900 - $2,512	25 Added 0.2%	12,372 $1.01 Million
Q4 2020 Feb 11, 2021	BUY	$80.74 - $97.7 $664,732 - $804,364	8,233 Added 200.12%	12,347 $1.07 Million
Q3 2020 Nov 12, 2020	BUY	$85.07 - $109.69 $349,977 - $451,264	4,114 New	4,114 $369,000
Q2 2020 Aug 13, 2020	SELL	$74.18 - $108.93 $243,087 - $356,963	-3,277 Closed	0 $0
Q1 2020 May 06, 2020	SELL	$63.18 - $85.97 $567,735 - $772,526	-8,986 Reduced 73.28%	3,277 $240,000
Q4 2019 Feb 10, 2020	BUY	$73.04 - $95.72 $82,023 - $107,493	1,123 Added 10.08%	12,263 $1.07 Million
Q3 2019 Nov 08, 2019	BUY	$72.82 - $86.52 $811,214 - $963,832	11,140 New	11,140 $827,000
Q1 2019 May 13, 2019	SELL	$63.56 - $88.17 $542,929 - $753,148	-8,542 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$58.5 - $69.94 $269,919 - $322,703	-4,614 Reduced 35.07%	8,542 $543,000
Q3 2018 Nov 06, 2018	BUY	$61.75 - $74.23 $498,137 - $598,813	8,067 Added 158.52%	13,156 $909,000
Q2 2018 Aug 10, 2018	BUY	$60.85 - $83.98 $68,456 - $94,477	1,125 Added 28.38%	5,089 $341,000
Q1 2018 May 07, 2018	BUY	$83.06 - $100.98 $149,341 - $181,562	1,798 Added 83.01%	3,964 $330,000
Q4 2017 Feb 06, 2018	SELL	$93.56 - $116.6 $238,952 - $297,796	-2,554 Reduced 54.11%	2,166 $205,000
Q3 2017 Nov 08, 2017	BUY	$109.15 - $138.27 $515,188 - $652,634	4,720	4,720 $551,000

Others Institutions Holding INCY

# of Institutions

643

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ing Groep Nv, based on Form 13F filings with the SEC.

News

Stay updated on Ing Groep Nv with notifications on news.

Account